Capital Fund Management S.A. Edwards Lifesciences Corp Call Options Transaction History

Capital Fund Management S.A.

$34.4 Billion
Q1 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $10.6 Million - $14 Million	-146,500 Reduced 26.44%	407,600 $39 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $25.4 Million - $32 Million	410,900 Added 286.94%	554,100 $42.3 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $7.87 Million - $10.6 Million	113,600 Added 383.78%	143,200 $9.92 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $3.82 Million - $4.42 Million	-46,900 Reduced 61.31%	29,600 $2.79 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $3.58 Million - $4.07 Million	48,200 Added 170.32%	76,500 $6.33 Million

Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $1.93 Million - $2.47 Million	28,300 New	28,300 $2.11 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $648,750 - $962,025	-7,500 Reduced 24.43%	23,200 $2.21 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $468,028 - $574,992	-4,400 Reduced 12.54%	30,700 $3.98 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $2.5 Million - $2.98 Million	24,300 Added 225.0%	35,100 $3.97 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $1.56 Million - $1.98 Million	-21,700 Reduced 66.77%	10,800 $985,000
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $450,173 - $585,848	6,700 Added 25.97%	32,500 $2.59 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.33 Million - $1.78 Million	23,100 Added 855.56%	25,800 $1.78 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $2.01 Million - $3.11 Million	-38,400 Reduced 93.43%	2,700 $169,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $1.63 Million - $1.86 Million	22,700 Added 123.37%	41,100 $9.59 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $880,165 - $1.08 Million	-14,300 Reduced 43.73%	18,400 $4.05 Million
Q2 2019 Aug 12, 2019	BUY	$55.74 - $64.41 $1.56 Million - $1.8 Million	28,000 Added 595.74%	32,700 $6.04 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $225,083 - $301,035	4,700 New	4,700 $899,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $1.33 Million - $1.68 Million	-29,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $12,735 - $15,390	-300 Reduced 1.02%	29,000 $4.22 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $899,998 - $1.15 Million	24,200 Added 474.51%	29,300 $4.09 Million
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $3,379 - $3,939	-100 Reduced 1.92%	5,100 $575,000
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $188,708 - $201,916	5,200	5,200 $568,000

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account